2-(7-amino-5-pyrrolidin-1-ylpyrazolo[1,5-a]pyrimidin-3-yl)sulfanylethanol;ethane;methanamine;N-methyl-2-phenylsulfanylprop-2-en-1-imine;5-pyrrolidin-1-yl-3-N,3-N-bis(thiophen-2-ylmethyl)pyrazolo[1,5-a]pyrimidine-3,7-diamine
C45H61N13OS4 — CID 145499972
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(7-amino-5-pyrrolidin-1-ylpyrazolo[1,5-a]pyrimidin-3-yl)sulfanylethanol;ethane;methanamine;N-methyl-2-phenylsulfanylprop-2-en-1-imine;5-pyrrolidin-1-yl-3-N,3-N-bis(thiophen-2-ylmethyl)pyrazolo[1,5-a]pyrimidine-3,7-diamine
2-(7-amino-5-pyrrolidin-1-ylpyrazolo[1,5-a]pyrimidin-3-yl)sulfanylethanol;ethane;methanamine;N-methyl-2-phenylsulfanylprop-2-en-1-imine;5-pyrrolidin-1-yl-3-N,3-N-bis(thiophen-2-ylmethyl)pyrazolo[1,5-a]pyrimidine-3,7-diamine (PubChem CID 145499972) has the molecular formula C45H61N13OS4 and a molecular weight of 928.34 g/mol. Its IUPAC name is 2-(7-amino-5-pyrrolidin-1-ylpyrazolo[1,5-a]pyrimidin-3-yl)sulfanylethanol;ethane;methanamine;N-methyl-2-phenylsulfanylprop-2-en-1-imine;5-pyrrolidin-1-yl-3-N,3-N-bis(thiophen-2-ylmethyl)pyrazolo[1,5-a]pyrimidine-3,7-diamine.
Molecular Properties
| Compound Name | 2-(7-amino-5-pyrrolidin-1-ylpyrazolo[1,5-a]pyrimidin-3-yl)sulfanylethanol;ethane;methanamine;N-methyl-2-phenylsulfanylprop-2-en-1-imine;5-pyrrolidin-1-yl-3-N,3-N-bis(thiophen-2-ylmethyl)pyrazolo[1,5-a]pyrimidine-3,7-diamine |
|---|---|
| PubChem CID | 145499972 |
| Molecular Formula | C45H61N13OS4 |
| Molecular Weight | 928.34 g/mol |
| Exact Mass | 927.40 |
| IUPAC Name | 2-(7-amino-5-pyrrolidin-1-ylpyrazolo[1,5-a]pyrimidin-3-yl)sulfanylethanol;ethane;methanamine;N-methyl-2-phenylsulfanylprop-2-en-1-imine;5-pyrrolidin-1-yl-3-N,3-N-bis(thiophen-2-ylmethyl)pyrazolo[1,5-a]pyrimidine-3,7-diamine |
| SMILES | C=C(/C=N/C)Sc1ccccc1.CC.CN.Nc1cc(N2CCCC2)nc2c(N(Cc3cccs3)Cc3cccs3)cnn12.Nc1cc(N2CCCC2)nc2c(SCCO)cnn12 |
| InChI | InChI=1S/C20H22N6S2.C12H17N5OS.C10H11NS.C2H6.CH5N/c21-18-11-19(24-7-1-2-8-24)23-20-17(12-22-26(18)20)25(13-15-5-3-9-27-15)14-16-6-4-10-28-16;13-10-7-11(16-3-1-2-4-16)15-12-9(19-6-5-18)8-14-17(10)12;1-9(8-11-2)12-10-6-4-3-5-7-10;2*1-2/h3-6,9-12H,1-2,7-8,13-14,21H2;7-8,18H,1-6,13H2;3-8H,1H2,2H3;1-2H3;2H2,1H3/b;;11-8+;; |
| InChIKey | HHCDQOYJAXSCKP-NVGJYZOFSA-N |
| XLogP | 8.83 |
| TPSA | 180.75 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 18 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 63 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 928.34 |
| LogP ≤ 5 | 8.83 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 18 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 145499972 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.